Related Experiment Videos
Platelets and cardiopulmonary bypass
J A Hyde1, J A Chinn, T R Graham
1Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, Birmingham. hyde@compuserve.com
Perfusion
|January 9, 1999
Summary
Cardiopulmonary bypass (CPB) can cause bleeding or clotting issues due to its effects on blood. Platelets are key players in these CPB-related hematological problems, though exact mechanisms require further study.
Area of Science:
- Hematology
- Cardiovascular Surgery
- Physiology
Background:
- Extracorporeal circulation, such as cardiopulmonary bypass (CPB), induces complex physiological responses.
- Hematological derangements are significant risks for patients undergoing CPB.
- CPB presents a paradox of factors promoting both bleeding and thrombosis.
Purpose of the Study:
- To investigate the role of platelets in CPB-related hemostatic dysfunction.
- To understand the mechanisms behind thrombotic complications associated with CPB.
- To inform clinical practice regarding CPB-induced hematological issues.
Main Methods:
- Review of clinical and laboratory evidence on platelet function during CPB.
- Analysis of factors influencing bleeding tendency and prothrombotic states.
- Examination of current understanding of platelet involvement in CPB complications.
Main Results:
- Platelets are critically involved in both bleeding and clotting complications during CPB.
- Existing research has elucidated some aspects of platelet function in CPB.
- The precise mechanisms of platelet involvement are not yet fully identified.
Conclusions:
- Platelet dysfunction and activation are central to CPB-related hematological derangements.
- Further research is needed to fully elucidate the complex mechanisms.
- Clinical management must rely on current evidence while awaiting further scientific understanding.